סימבקסון 40

Država: Izrael

Jezik: hebrejski

Izvor: Ministry of Health

Aktivni sastojci:

SIMVASTATIN

Dostupno od:

DEXCEL PHARMA TECHNOLOGIES LTD

ATC koda:

C10AA01

Farmaceutski oblik:

קפליות

Sastav:

SIMVASTATIN 40 MG

Administracija rute:

פומי

Tip recepta:

מרשם נדרש

Proizveden od:

DEXCEL LTD, ISRAEL

Terapijska grupa:

SIMVASTATIN

Područje terapije:

SIMVASTATIN

Terapijske indikacije:

Coronary Heart Disease : In patients with coronary heart disease and hypercholesterolemia Simvaxon is indicated to: - Reduce the risk of total mortality by reducing coronary death - Reduce the risk of non-fatal myocardial infarction - Reduce the risk for undergoing myocardial revascularization procedures - Reduce the risk of stroke and transient ischemic attacks (TIA's). Hyperlipidemia: Simvaxon is indicated as an adjunct to diet to reduce elevated TOTAL-C LDL-C Apo B and TG and to increase HDL-C in patients with primary hypercholesterolemia ( heterozygous familial and nonfamilial) and mixed dyslipidemia (Frederickson Types IIa and IIb) Simvaxon therefore lowers the LDL-C/HDL-C and the total-C/HDL-C ratios. Homozygous familial hypercholesterolemia: Simvaxon is also indicated as an adjunct to diet and other non-dietary measures in reducing elevated total cholesterol LDL-cholesterol and apolipoprotein B in patients with homozygous familial hypercholesterolemia when response to these measures is inadequate. Hype

Proizvod sažetak:

Atorvastatin, Cerivastatin, Fluvastatin, Lovastatin, Pravastatin, Simvastatin

Datum autorizacije:

2020-04-30